species: Homo sapiens studyId: syn51133946 studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial accessType: PRIVATE fileFormat: bai initiative: DHART-SPORE Project 3 isCellLine: No dataSubtype: raw individualID: HM5025 resourceType: experimentalData fundingAgency: NIH-NCI isMultiSpecimen: No isMultiIndividual: No
Drop files to upload
57890253_HM5025_0000281BDL.tumor.abra.bai page is loading…